NDAQ vs. CME
NDAQ (Nasdaq, Inc.) and CME (CME Group Inc.) are both stocks. Both operate in the Financial Data & Stock Exchanges industry within the Financial Services sector. Over the past 10 years, NDAQ returned 16.73%/yr vs 14.41%/yr for CME. At a 0.45 correlation, their price movements are largely independent.
Performance
NDAQ vs. CME - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NDAQ achieves a -10.34% return, which is significantly lower than CME's -5.27% return. Over the past 10 years, NDAQ has outperformed CME with an annualized return of 16.73%, while CME has yielded a comparatively lower 14.41% annualized return.
NDAQ
- 1D
- -1.25%
- 1M
- -4.92%
- YTD
- -10.34%
- 6M
- -1.10%
- 1Y
- 4.84%
- 3Y*
- 17.14%
- 5Y*
- 10.36%
- 10Y*
- 16.73%
CME
- 1D
- 0.84%
- 1M
- -12.97%
- YTD
- -5.27%
- 6M
- -5.27%
- 1Y
- -7.08%
- 3Y*
- 15.77%
- 5Y*
- 7.35%
- 10Y*
- 14.41%
NDAQ vs. CME - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NDAQ Nasdaq, Inc. | -10.34% | 27.19% | 34.85% | -3.66% | -11.19% | 60.13% | 25.99% | 33.88% | 8.21% | 16.76% |
CME CME Group Inc. | -5.27% | 19.83% | 15.41% | 31.32% | -22.89% | 29.47% | -6.34% | 9.67% | 32.15% | 32.35% |
Correlation
The correlation between NDAQ and CME is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.37 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.46 |
Correlation (All Time) Calculated using the full available price history since Dec 9, 2002 | 0.45 |
The correlation between NDAQ and CME shifts across timeframes, from 0.23 (3 years) to 0.46 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
NDAQ:
$49.63B
CME:
$91.76B
NDAQ:
$3.32
CME:
$11.75
NDAQ:
26.16
CME:
21.50
NDAQ:
2.51
CME:
1.88
NDAQ:
6.06
CME:
13.50
NDAQ:
4.12
CME:
3.45
NDAQ:
$8.27B
CME:
$6.76B
NDAQ:
$4.53B
CME:
$5.84B
NDAQ:
$3.11B
CME:
$5.69B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NDAQ vs. CME — Risk / Return Rank
NDAQ
CME
NDAQ vs. CME - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nasdaq, Inc. (NDAQ) and CME Group Inc. (CME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NDAQ | CME | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.55 | ||
| Sortino ratioReturn per unit of downside risk | +0.76 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 0.96 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | 0.22 | -0.33 | +0.56 |
| Martin ratioReturn relative to average drawdown | 0.52 | -1.19 | +1.71 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NDAQ | CME | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.20 | -0.35 | +0.55 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.44 | 0.37 | +0.07 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.69 | 0.61 | +0.09 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.37 | 0.59 | -0.21 |
Drawdowns
NDAQ vs. CME - Drawdown Comparison
The maximum NDAQ drawdown since its inception was -68.48%, smaller than the maximum CME drawdown of -77.50%. Use the drawdown chart below to compare losses from any high point for NDAQ and CME.
Loading charts...
Drawdown Indicators
| NDAQ | CME | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.48% | -77.50% | +9.02% |
Max Drawdown (1Y)Largest decline over 1 year | -21.76% | -21.42% | -0.34% |
Max Drawdown (3Y)Largest decline over 3 years | -21.76% | -21.42% | -0.34% |
Max Drawdown (5Y)Largest decline over 5 years | -32.84% | -31.74% | -1.10% |
Max Drawdown (10Y)Largest decline over 10 years | -38.31% | -37.36% | -0.95% |
Current DrawdownCurrent decline from peak | -13.76% | -20.76% | +7.00% |
Average DrawdownAverage peak-to-trough decline | -23.82% | -20.69% | -3.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.24% | 6.03% | +3.21% |
Volatility
NDAQ vs. CME - Volatility Comparison
The current volatility for Nasdaq, Inc. (NDAQ) is 7.32%, while CME Group Inc. (CME) has a volatility of 9.91%. This indicates that NDAQ experiences smaller price fluctuations and is considered to be less risky than CME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NDAQ | CME | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.32% | 9.91% | -2.59% |
Volatility (6M)Calculated over the trailing 6-month period | 20.64% | 16.74% | +3.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.43% | 20.47% | +3.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.94% | 20.03% | +3.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.25% | 23.87% | +0.38% |
Dividends
NDAQ vs. CME - Dividend Comparison
NDAQ's dividend yield for the trailing twelve months is around 1.24%, less than CME's 4.43% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CME CME Group Inc. | 4.43% | 1.83% | 4.48% | 4.58% | 5.05% | 3.00% | 3.24% | 2.74% | 2.42% | 4.20% | 4.90% | 5.41% |
NDAQ Nasdaq, Inc. | 1.24% | 1.08% | 1.22% | 1.48% | 1.27% | 1.00% | 1.46% | 1.73% | 2.08% | 1.90% | 1.80% | 1.55% |
Financials
NDAQ vs. CME - Financials Comparison
This section allows you to compare key financial metrics between Nasdaq, Inc. and CME Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NDAQ vs. CME - Profitability Comparison
NDAQ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nasdaq, Inc. reported a gross profit of 1.41B and revenue of 2.14B. Therefore, the gross margin over that period was 65.8%.
CME - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported a gross profit of 1.66B and revenue of 1.88B. Therefore, the gross margin over that period was 88.1%.
NDAQ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nasdaq, Inc. reported an operating income of 657.00M and revenue of 2.14B, resulting in an operating margin of 30.7%.
CME - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported an operating income of 1.31B and revenue of 1.88B, resulting in an operating margin of 69.7%.
NDAQ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nasdaq, Inc. reported a net income of 519.00M and revenue of 2.14B, resulting in a net margin of 24.3%.
CME - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported a net income of 1.15B and revenue of 1.88B, resulting in a net margin of 61.4%.
Frequently Asked Questions
NDAQ and CME have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CME has higher volatility (9.91%) compared to NDAQ (7.32%). In terms of maximum drawdown, NDAQ dropped -68.48% vs CME's -77.50%.
NDAQ currently has the higher Sharpe Ratio (0.20 vs -0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NDAQ and CME
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer